Ono Pharmaceutical Co., Ltd.;HOFFMANN-LA ROCHE INC.
发明人:
Christian Klein,Toshio Yoshizawa,Tomoko Yasuhiro
申请号：
US16679483
公开号：
US20200171153A1
申请日:
2019.11.11
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention is directed to the combination therapy of an anti-CD20 antibody with a BTK inhibitor for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with a type I anti-CD20 antibody or an afucosylated humanized B-Ly1 antibody and a BTK inhibitor.
